Search - tctmd.com

Displaying 541 - 560 of 620

Sort: Relevancy | Date

News Industry News

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

June 11, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

Presentation CTO 2014

Left Main Restenosis: Incidence, Implications, and Management

Presenter: Roxana Mehran

March 01, 2014

Presentation CTO 2014

Dedicated Bifurcation Stents in Left Main Disease: Do the Data Support Their Need?

Presenter: Martin B. Leon

March 01, 2014

Presentation CTO 2014

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Presenter: Antonio Colombo

March 01, 2014

Presentation CTO 2014

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Presenter: Philippe Généreux

March 01, 2014

News Daily News

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Yael L. Maxwell

February 26, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

News Daily News

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

January 22, 2014

News Daily News

RIBS V Publicado: Buenos Resultados con BLF y SLE en el Tratamiento de Pacientes con Reestenosis intra Stent del SMD

January 22, 2014

Presentation

Role of Drug Coated Balloons in Acute Coronary Syndrome

Presenter: Bruno Scheller

December 02, 2013

Presentation

Drug-Coated Balloons for Treatment of Coronary Artery Disease: Updated Recommendations from a Consensus Group

Presenter: Bruno Scheller

December 01, 2013

Presentation TCT 2013

Trial Design and Regulatory Pathways for Drug-Coated Balloons in BTK Intervention: Anatomy, Patients and Endpoints

Presenter: William Gray

October 31, 2013

Presentation TCT 2013

CON: Drug-Coated Balloons are Effective at the Arterial Level, But Not Necessarily for the Patient!

Presenter: Michael Conte

October 31, 2013

Presentation TCT 2013

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Presenter: Thomas Zeller

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

Presenter: Ron Waksman

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Presenter: Christoph Naber

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data(2)

Presenter: Franz Kleber

October 31, 2013

Advertisement

Medtronic Submits Final Data to FDA for Novel Device to Treat Peripheral Artery Disease

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Left Main Restenosis: Incidence, Implications, and Management

Dedicated Bifurcation Stents in Left Main Disease: Do the Data Support Their Need?

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

RIBS V Publicado: Buenos Resultados con BLF y SLE en el Tratamiento de Pacientes con Reestenosis intra Stent del SMD

Role of Drug Coated Balloons in Acute Coronary Syndrome

Drug-Coated Balloons for Treatment of Coronary Artery Disease: Updated Recommendations from a Consensus Group

Trial Design and Regulatory Pathways for Drug-Coated Balloons in BTK Intervention: Anatomy, Patients and Endpoints

CON: Drug-Coated Balloons are Effective at the Arterial Level, But Not Necessarily for the Patient!

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data(2)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content